LASIK vs LASEK vs PRK: advantages and indications
- PMID: 12759854
- DOI: 10.1076/soph.18.1.2.14074
LASIK vs LASEK vs PRK: advantages and indications
Abstract
The advent of the excimer laser as an instrument for use in reshaping the corneal stroma was a great step forward in refractive surgery. Laser energy can be delivered on the stromal surface in the photorefractive keratectomy (PRK) procedure or deeper on the corneal stroma by the means of a lamellar surgery in which a flap is created with the microkeratome in the laser in situ keratomileusis (LASIK) procedure. LASIK is currently the dominant procedure in refractive surgery. The main advantage of LASIK over PRK is related to maintaining the central corneal epithelium. This increases comfort during the early post-operative period, allows for rapid visual recovery, and reduces the wound healing response. Reduced wound healing correlates with less regression for high corrections and a lower rate of complications such as significant stromal opacity (haze). PRK, however, remains as an excellent option for mild to moderate corrections, particularly for cases associated with thin corneas, recurrent erosions, or a predisposition for trauma (Martial arts, military, etc.). Recently, a modification of PRK, laser subepithelial keratomileusis (LASEK), was introduced. In the LASEK procedure, an epithelial flap is created and replaced after the ablation. The benefits, if any, of the creation of an epithelial flap compared to traditional PRK are not fully appreciated. Advocates of LASEK suggest that there is less discomfort in the early postoperative period, faster visual recovery, and less haze compared to standard PRK for correction of similar levels of refractive error. Additional long-term clinical studies, along with laboratory research, will be crucial to validate these potential advantages of LASEK procedure.
Similar articles
-
Laser in situ keratomileusis versus surface ablation: visual outcomes and complications.J Cataract Refract Surg. 2007 Dec;33(12):2041-8. doi: 10.1016/j.jcrs.2007.07.026. J Cataract Refract Surg. 2007. PMID: 18053901
-
Laser-assisted subepithelial keratectomy for myopia: two-year follow-up.J Cataract Refract Surg. 2003 Apr;29(4):661-8. doi: 10.1016/s0886-3350(02)01897-7. J Cataract Refract Surg. 2003. PMID: 12686232 Clinical Trial.
-
A randomized prospective clinical trial comparing laser subepithelial keratomileusis and photorefractive keratectomy.Arch Ophthalmol. 2004 Jan;122(1):11-6. doi: 10.1001/archopht.122.1.11. Arch Ophthalmol. 2004. PMID: 14718288 Clinical Trial.
-
LASEK (laser subepithelial keratomileusis).Curr Opin Ophthalmol. 2002 Aug;13(4):261-3. doi: 10.1097/00055735-200208000-00014. Curr Opin Ophthalmol. 2002. PMID: 12165712 Review.
-
Evolution, techniques, clinical outcomes, and pathophysiology of LASEK: review of the literature.Surv Ophthalmol. 2004 Nov-Dec;49(6):576-602. doi: 10.1016/j.survophthal.2004.08.003. Surv Ophthalmol. 2004. PMID: 15530945 Review.
Cited by
-
Myopic Laser-Assisted Subepithelial Keratectomy (LASEK) outcomes using three different excimer laser platforms: a retrospective observational study.BMC Ophthalmol. 2019 Oct 15;19(1):205. doi: 10.1186/s12886-019-1214-y. BMC Ophthalmol. 2019. PMID: 31615462 Free PMC article.
-
Comparison of pain after subepithelial versus conventional accelerated corneal collagen cross-linking for keratoconus.Int Ophthalmol. 2019 Jun;39(6):1249-1254. doi: 10.1007/s10792-018-0935-x. Epub 2018 May 7. Int Ophthalmol. 2019. PMID: 29736691
-
Histopathological study of corneal flap striae following laser in situ keratomileusis in rabbits.Exp Ther Med. 2015 Mar;9(3):895-900. doi: 10.3892/etm.2015.2171. Epub 2015 Jan 8. Exp Ther Med. 2015. PMID: 25667649 Free PMC article.
-
Four-year to seven-year outcomes of advanced surface ablation with excimer laser for high myopia.Graefes Arch Clin Exp Ophthalmol. 2015 Jul;253(7):1027-33. doi: 10.1007/s00417-014-2920-z. Epub 2015 Jan 13. Graefes Arch Clin Exp Ophthalmol. 2015. PMID: 25582070
-
Z-LASIK and Trans-PRK for correction of high-grade myopia: safety, efficacy, predictability and clinical outcomes.Int Ophthalmol. 2019 Apr;39(4):753-763. doi: 10.1007/s10792-018-0868-4. Epub 2018 Mar 12. Int Ophthalmol. 2019. PMID: 29532217
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical